Susquehanna International Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$793K Buy
+25,200
New +$794K ﹤0.01% 8495
2025
Q4
Sell
-8,400
Closed -$212K 13432
2025
Q3
$212K Buy
+8,400
New +$205K ﹤0.01% 10870
2025
Q2
Sell
-17,400
Closed -$398K 13580
2025
Q1
$398K Sell
17,400
-83,900
-83% -$2.02M ﹤0.01% 9406
2024
Q4
$2.56M Sell
101,300
-23,900
-19% -$606K ﹤0.01% 4767
2024
Q3
$3.12M Buy
125,200
+56,600
+83% +$1.68M ﹤0.01% 4466
2024
Q2
$2.03M Sell
68,600
-147,600
-68% -$4.09M ﹤0.01% 5068
2024
Q1
$6.52M Buy
+216,200
New +$6M ﹤0.01% 3215

Other funds holding RTO

Susquehanna International Group's RTO Position: Q2 2025 in Review

Susquehanna International Group sold out of Rentokil (RTO) in Q2 2025, closing a stake of 28,470 shares — an estimated $660K sold.

Susquehanna International Group first reported a position in RTO in Q4 2022 and held it in 4 quarters. The position peaked at $5.82M in Q4 2022. 206 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Susquehanna International Group reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 28,470 Rentokil shares in Q2 2025, an estimated $660K.
  • Susquehanna International Group first reported a position in Rentokil in Q4 2022 and held it in 4 quarters.
  • Susquehanna International Group's Rentokil position peaked at $5.82M in Q4 2022.
  • 206 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.